Jellen: Difference between revisions

From Ephinea PSO Wiki
mNo edit summary
Line 37: Line 37:
! rowspan="2" | TP <br />Cost
! rowspan="2" | TP <br />Cost
! rowspan="2" | MST <br />Required<br />To Learn
! rowspan="2" | MST <br />Required<br />To Learn
! rowspan="2" | Duration <br />in<br />Seconds
! colspan="2" | Targeting Range
! colspan="2" | Targeting Range
! colspan="2" | Targeting Angle
! colspan="2" | Targeting Angle
Line 45: Line 46:
| style="font-size:x-small;" | Vertical
| style="font-size:x-small;" | Vertical
|-
|-
| style="font-weight:bold;" | 1
| style="font-weight:bold;" |1
| style="vertical-align:middle; background-color:#F4CCCC;" | 10
| style="vertical-align:middle; background-color:#F4CCCC;" |10
| style="vertical-align:middle; background-color:#C9DAF8;" | 10
| style="vertical-align:middle; background-color:#C9DAF8;" |10
| style="vertical-align:middle; background-color:#D9D2E9;" | 60
| style="vertical-align:middle; background-color:#D9D2E9;" |60
| style="vertical-align:middle; background-color:#F4CCCC;" |40
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?  
|-
|-
| style="font-weight:bold;" | 2
| style="font-weight:bold;" |2
| style="vertical-align:middle; background-color:#F4CCCC;" | 11.3
| style="vertical-align:middle; background-color:#F4CCCC;" |11.3
| style="vertical-align:middle; background-color:#C9DAF8;" | 11
| style="vertical-align:middle; background-color:#C9DAF8;" |11
| style="vertical-align:middle; background-color:#D9D2E9;" | 88
| style="vertical-align:middle; background-color:#D9D2E9;" |88
| style="vertical-align:middle; background-color:#F4CCCC;" |50
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 63: Line 66:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 3
| style="font-weight:bold;" |3
| style="vertical-align:middle; background-color:#F4CCCC;" | 12.6
| style="vertical-align:middle; background-color:#F4CCCC;" |12.6
| style="vertical-align:middle; background-color:#C9DAF8;" | 12
| style="vertical-align:middle; background-color:#C9DAF8;" |12
| style="vertical-align:middle; background-color:#D9D2E9;" | 116
| style="vertical-align:middle; background-color:#D9D2E9;" |116
| style="vertical-align:middle; background-color:#F4CCCC;" |60
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 72: Line 76:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 4
| style="font-weight:bold;" |4
| style="vertical-align:middle; background-color:#F4CCCC;" | 13.9
| style="vertical-align:middle; background-color:#F4CCCC;" |13.9
| style="vertical-align:middle; background-color:#C9DAF8;" | 13
| style="vertical-align:middle; background-color:#C9DAF8;" |13
| style="vertical-align:middle; background-color:#D9D2E9;" | 144
| style="vertical-align:middle; background-color:#D9D2E9;" |144
| style="vertical-align:middle; background-color:#F4CCCC;" |70
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 81: Line 86:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 5
| style="font-weight:bold;" |5
| style="vertical-align:middle; background-color:#F4CCCC;" | 15.2
| style="vertical-align:middle; background-color:#F4CCCC;" |15.2
| style="vertical-align:middle; background-color:#C9DAF8;" | 14
| style="vertical-align:middle; background-color:#C9DAF8;" |14
| style="vertical-align:middle; background-color:#D9D2E9;" | 172
| style="vertical-align:middle; background-color:#D9D2E9;" |172
| style="vertical-align:middle; background-color:#F4CCCC;" |80
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 90: Line 96:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 6
| style="font-weight:bold;" |6
| style="vertical-align:middle; background-color:#F4CCCC;" | 16.5
| style="vertical-align:middle; background-color:#F4CCCC;" |16.5
| style="vertical-align:middle; background-color:#C9DAF8;" | 15
| style="vertical-align:middle; background-color:#C9DAF8;" |15
| style="vertical-align:middle; background-color:#D9D2E9;" | 200
| style="vertical-align:middle; background-color:#D9D2E9;" |200
| style="vertical-align:middle; background-color:#F4CCCC;" |90
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 99: Line 106:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 7
| style="font-weight:bold;" |7
| style="vertical-align:middle; background-color:#F4CCCC;" | 17.8
| style="vertical-align:middle; background-color:#F4CCCC;" |17.8
| style="vertical-align:middle; background-color:#C9DAF8;" | 16
| style="vertical-align:middle; background-color:#C9DAF8;" |16
| style="vertical-align:middle; background-color:#D9D2E9;" | 228
| style="vertical-align:middle; background-color:#D9D2E9;" |228
| style="vertical-align:middle; background-color:#F4CCCC;" |100
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 108: Line 116:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 8
| style="font-weight:bold;" |8
| style="vertical-align:middle; background-color:#F4CCCC;" | 18.1
| style="vertical-align:middle; background-color:#F4CCCC;" |18.1
| style="vertical-align:middle; background-color:#C9DAF8;" | 17
| style="vertical-align:middle; background-color:#C9DAF8;" |17
| style="vertical-align:middle; background-color:#D9D2E9;" | 256
| style="vertical-align:middle; background-color:#D9D2E9;" |256
| style="vertical-align:middle; background-color:#F4CCCC;" |110
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 117: Line 126:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 9
| style="font-weight:bold;" |9
| style="vertical-align:middle; background-color:#F4CCCC;" | 20.4
| style="vertical-align:middle; background-color:#F4CCCC;" |20.4
| style="vertical-align:middle; background-color:#C9DAF8;" | 18
| style="vertical-align:middle; background-color:#C9DAF8;" |18
| style="vertical-align:middle; background-color:#D9D2E9;" | 284
| style="vertical-align:middle; background-color:#D9D2E9;" |284
| style="vertical-align:middle; background-color:#F4CCCC;" |120
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 126: Line 136:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 10
| style="font-weight:bold;" |10
| style="vertical-align:middle; background-color:#F4CCCC;" | 21.7
| style="vertical-align:middle; background-color:#F4CCCC;" |21.7
| style="vertical-align:middle; background-color:#C9DAF8;" | 19
| style="vertical-align:middle; background-color:#C9DAF8;" |19
| style="vertical-align:middle; background-color:#D9D2E9;" | 312
| style="vertical-align:middle; background-color:#D9D2E9;" |312
| style="vertical-align:middle; background-color:#F4CCCC;" |130
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 135: Line 146:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 11
| style="font-weight:bold;" |11
| style="vertical-align:middle; background-color:#F4CCCC;" | 23
| style="vertical-align:middle; background-color:#F4CCCC;" |23
| style="vertical-align:middle; background-color:#C9DAF8;" | 20
| style="vertical-align:middle; background-color:#C9DAF8;" |20
| style="vertical-align:middle; background-color:#D9D2E9;" | 340
| style="vertical-align:middle; background-color:#D9D2E9;" |340
| style="vertical-align:middle; background-color:#F4CCCC;" |140
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 144: Line 156:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 12
| style="font-weight:bold;" |12
| style="vertical-align:middle; background-color:#F4CCCC;" | 24.3
| style="vertical-align:middle; background-color:#F4CCCC;" |24.3
| style="vertical-align:middle; background-color:#C9DAF8;" | 21
| style="vertical-align:middle; background-color:#C9DAF8;" |21
| style="vertical-align:middle; background-color:#D9D2E9;" | 368
| style="vertical-align:middle; background-color:#D9D2E9;" |368
| style="vertical-align:middle; background-color:#F4CCCC;" |150
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 153: Line 166:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 13
| style="font-weight:bold;" |13
| style="vertical-align:middle; background-color:#F4CCCC;" | 25.6
| style="vertical-align:middle; background-color:#F4CCCC;" |25.6
| style="vertical-align:middle; background-color:#C9DAF8;" | 22
| style="vertical-align:middle; background-color:#C9DAF8;" |22
| style="vertical-align:middle; background-color:#D9D2E9;" | 396
| style="vertical-align:middle; background-color:#D9D2E9;" |396
| style="vertical-align:middle; background-color:#F4CCCC;" |160
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 162: Line 176:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 14
| style="font-weight:bold;" |14
| style="vertical-align:middle; background-color:#F4CCCC;" | 26.9
| style="vertical-align:middle; background-color:#F4CCCC;" |26.9
| style="vertical-align:middle; background-color:#C9DAF8;" | 23
| style="vertical-align:middle; background-color:#C9DAF8;" |23
| style="vertical-align:middle; background-color:#D9D2E9;" | 424
| style="vertical-align:middle; background-color:#D9D2E9;" |424
| style="vertical-align:middle; background-color:#F4CCCC;" |170
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 171: Line 186:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 15
| style="font-weight:bold;" |15
| style="vertical-align:middle; background-color:#F4CCCC;" | 28.2
| style="vertical-align:middle; background-color:#F4CCCC;" |28.2
| style="vertical-align:middle; background-color:#C9DAF8;" | 24
| style="vertical-align:middle; background-color:#C9DAF8;" |24
| style="vertical-align:middle; background-color:#D9D2E9;" | 452
| style="vertical-align:middle; background-color:#D9D2E9;" |452
| style="vertical-align:middle; background-color:#F4CCCC;" |180
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 180: Line 196:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 16
| style="font-weight:bold;" |16
| style="vertical-align:middle; background-color:#F4CCCC;" | 29.5
| style="vertical-align:middle; background-color:#F4CCCC;" |29.5
| style="vertical-align:middle; background-color:#C9DAF8;" | 25
| style="vertical-align:middle; background-color:#C9DAF8;" |25
| style="vertical-align:middle; background-color:#D9D2E9;" | 480
| style="vertical-align:middle; background-color:#D9D2E9;" |480
| style="vertical-align:middle; background-color:#F4CCCC;" |190
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 189: Line 206:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 17
| style="font-weight:bold;" |17
| style="vertical-align:middle; background-color:#F4CCCC;" | 30.8
| style="vertical-align:middle; background-color:#F4CCCC;" |30.8
| style="vertical-align:middle; background-color:#C9DAF8;" | 26
| style="vertical-align:middle; background-color:#C9DAF8;" |26
| style="vertical-align:middle; background-color:#D9D2E9;" | 508
| style="vertical-align:middle; background-color:#D9D2E9;" |508
| style="vertical-align:middle; background-color:#F4CCCC;" |200
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 198: Line 216:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 18
| style="font-weight:bold;" |18
| style="vertical-align:middle; background-color:#F4CCCC;" | 32.1
| style="vertical-align:middle; background-color:#F4CCCC;" |32.1
| style="vertical-align:middle; background-color:#C9DAF8;" | 27
| style="vertical-align:middle; background-color:#C9DAF8;" |27
| style="vertical-align:middle; background-color:#D9D2E9;" | 536
| style="vertical-align:middle; background-color:#D9D2E9;" |536
| style="vertical-align:middle; background-color:#F4CCCC;" |210
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 207: Line 226:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 19
| style="font-weight:bold;" |19
| style="vertical-align:middle; background-color:#F4CCCC;" | 33.4
| style="vertical-align:middle; background-color:#F4CCCC;" |33.4
| style="vertical-align:middle; background-color:#C9DAF8;" | 28
| style="vertical-align:middle; background-color:#C9DAF8;" |28
| style="vertical-align:middle; background-color:#D9D2E9;" | 564
| style="vertical-align:middle; background-color:#D9D2E9;" |564
| style="vertical-align:middle; background-color:#F4CCCC;" |220
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 216: Line 236:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 20
| style="font-weight:bold;" |20
| style="vertical-align:middle; background-color:#F4CCCC;" | 34.7
| style="vertical-align:middle; background-color:#F4CCCC;" |34.7
| style="vertical-align:middle; background-color:#C9DAF8;" | 29
| style="vertical-align:middle; background-color:#C9DAF8;" |29
| style="vertical-align:middle; background-color:#D9D2E9;" | 592
| style="vertical-align:middle; background-color:#D9D2E9;" | 592
| style="vertical-align:middle; background-color:#F4CCCC;" |230
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 225: Line 246:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 21
| style="font-weight:bold;" |21
| style="vertical-align:middle; background-color:#F4CCCC;" | 36
| style="vertical-align:middle; background-color:#F4CCCC;" |36
| style="vertical-align:middle; background-color:#C9DAF8;" | 30
| style="vertical-align:middle; background-color:#C9DAF8;" | 30
| style="vertical-align:middle; background-color:#D9D2E9;" | 620
| style="vertical-align:middle; background-color:#D9D2E9;" |620  
| style="vertical-align:middle; background-color:#F4CCCC;" |240
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 235: Line 257:
|-
|-
| style="font-weight:bold;" | 22
| style="font-weight:bold;" | 22
| style="vertical-align:middle; background-color:#F4CCCC;" | 37.3
| style="vertical-align:middle; background-color:#F4CCCC;" |37.3  
| style="vertical-align:middle; background-color:#C9DAF8;" | 31
| style="vertical-align:middle; background-color:#C9DAF8;" |31
| style="vertical-align:middle; background-color:#D9D2E9;" | 648
| style="vertical-align:middle; background-color:#D9D2E9;" |648
| style="background-color:#fff2cc;" | ?
| style="vertical-align:middle; background-color:#F4CCCC;" |250
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?  
| style="background-color:#c9ff00;" | ?
| style="background-color:#fff2cc;" | ?  
| style="background-color:#c9ff00;" | ?  
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 23
| style="font-weight:bold;" |23
| style="vertical-align:middle; background-color:#F4CCCC;" | 38.6
| style="vertical-align:middle; background-color:#F4CCCC;" |38.6
| style="vertical-align:middle; background-color:#C9DAF8;" | 32
| style="vertical-align:middle; background-color:#C9DAF8;" |32
| style="vertical-align:middle; background-color:#D9D2E9;" | 676
| style="vertical-align:middle; background-color:#D9D2E9;" | 676
| style="vertical-align:middle; background-color:#F4CCCC;" |260
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 252: Line 276:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 24
| style="font-weight:bold;" |24
| style="vertical-align:middle; background-color:#F4CCCC;" | 39.9
| style="vertical-align:middle; background-color:#F4CCCC;" |39.9
| style="vertical-align:middle; background-color:#C9DAF8;" | 33
| style="vertical-align:middle; background-color:#C9DAF8;" | 33
| style="vertical-align:middle; background-color:#D9D2E9;" | 704
| style="vertical-align:middle; background-color:#D9D2E9;" |704
| style="vertical-align:middle; background-color:#F4CCCC;" |270
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 261: Line 286:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 25
| style="font-weight:bold;" |25
| style="vertical-align:middle; background-color:#F4CCCC;" | 41.2
| style="vertical-align:middle; background-color:#F4CCCC;" | 41.2
| style="vertical-align:middle; background-color:#C9DAF8;" | 34
| style="vertical-align:middle; background-color:#C9DAF8;" |34  
| style="vertical-align:middle; background-color:#D9D2E9;" | 732
| style="vertical-align:middle; background-color:#D9D2E9;" | 732  
| style="background-color:#fff2cc;" | ?
| style="vertical-align:middle; background-color:#F4CCCC;" |280
| style="background-color:#fff2cc;" | ?  
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
Line 271: Line 297:
|-
|-
| style="font-weight:bold;" | 26
| style="font-weight:bold;" | 26
| style="vertical-align:middle; background-color:#F4CCCC;" | 42.5
| style="vertical-align:middle; background-color:#F4CCCC;" |42.5
| style="vertical-align:middle; background-color:#C9DAF8;" | 35
| style="vertical-align:middle; background-color:#C9DAF8;" | 35
| style="vertical-align:middle; background-color:#D9D2E9;" | 760
| style="vertical-align:middle; background-color:#D9D2E9;" |760
| style="background-color:#fff2cc;" | ?
| style="vertical-align:middle; background-color:#F4CCCC;" |290
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?  
| style="background-color:#c9ff00;" | ?
| style="background-color:#fff2cc;" | ?  
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?  
| style="background-color:#c9ff00;" | ?  
|-
|-
| style="font-weight:bold;" | 27
| style="font-weight:bold;" |27  
| style="vertical-align:middle; background-color:#F4CCCC;" | 43.8
| style="vertical-align:middle; background-color:#F4CCCC;" | 43.8
| style="vertical-align:middle; background-color:#C9DAF8;" | 36
| style="vertical-align:middle; background-color:#C9DAF8;" |36  
| style="vertical-align:middle; background-color:#D9D2E9;" | 788
| style="vertical-align:middle; background-color:#D9D2E9;" |788  
| style="vertical-align:middle; background-color:#F4CCCC;" |300
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
| style="font-weight:bold;" |28
| style="vertical-align:middle; background-color:#F4CCCC;" |45.1
| style="vertical-align:middle; background-color:#C9DAF8;" |37
| style="vertical-align:middle; background-color:#D9D2E9;" |816
| style="vertical-align:middle; background-color:#F4CCCC;" |310
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 288: Line 326:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 28
| style="font-weight:bold;" |29
| style="vertical-align:middle; background-color:#F4CCCC;" | 45.1
| style="vertical-align:middle; background-color:#F4CCCC;" |46.4
| style="vertical-align:middle; background-color:#C9DAF8;" | 37
| style="vertical-align:middle; background-color:#C9DAF8;" |38
| style="vertical-align:middle; background-color:#D9D2E9;" | 816
| style="vertical-align:middle; background-color:#D9D2E9;" |844
| style="vertical-align:middle; background-color:#F4CCCC;" |320
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 297: Line 336:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 29
| style="font-weight:bold;" |30
| style="vertical-align:middle; background-color:#F4CCCC;" | 46.4
| style="vertical-align:middle; background-color:#F4CCCC;" |47.7
| style="vertical-align:middle; background-color:#C9DAF8;" | 38
| style="vertical-align:middle; background-color:#C9DAF8;" |39
| style="vertical-align:middle; background-color:#D9D2E9;" | 844
| style="vertical-align:middle; background-color:#D9D2E9;" |872
| style="vertical-align:middle; background-color:#F4CCCC;" |330
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 306: Line 346:
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|-
|-
| style="font-weight:bold;" | 30
| style="vertical-align:middle; background-color:#F4CCCC;" | 47.7
| style="vertical-align:middle; background-color:#C9DAF8;" | 39
| style="vertical-align:middle; background-color:#D9D2E9;" | 872
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#c9ff00;" | ?
| style="background-color:#c9ff00;" | ?
|}
|}
{{Techs}}
{{Techs}}
[[Category:Techniques]]
[[Category:Techniques]]

Revision as of 23:58, 13 March 2023

Disk icon.pngJellen
ジェレン
Jellen
Type
:
Support
HUmrHUnlHUctHUcl
15 20 ××
RAmrRAmlRActRAcl
× 20 ××
FOmrFOmlFOnmFOnl
30 30 30 30
Attack-weakening technique.
Can affect enemies near the target.

Jellen.pngJellen is a support technique that lowers the ATP of a group of enemies.

It reduces the ATP of the target enemy, and other nearby enemies, by a percentage that increases with its level.

Its duration and range is also improved with its level.

Migium casts Jellen.pngJellen and Zalure.pngZalure with its melee attack, and Gi Gue casts Jellen.pngJellen and Zalure.pngZalure as a standalone attack.

Details

Boosting Equipment

There is only a single item in Phantasy Star Online Blue Burst that raises the range of Jellen.pngJellen:

Level Progression

Jellen.pngJellen's statistics improve when its level increases, but the MST required to learn it and TP required to cast it increase as well.

Lv ATP
Reduction
(%)
TP
Cost
MST
Required
To Learn
Duration
in
Seconds
Targeting Range Targeting Angle
Horizontal Vertical Horizontal Vertical
1 10 10 60 40 ? ? ? ?
2 11.3 11 88 50 ? ? ? ?
3 12.6 12 116 60 ? ? ? ?
4 13.9 13 144 70 ? ? ? ?
5 15.2 14 172 80 ? ? ? ?
6 16.5 15 200 90 ? ? ? ?
7 17.8 16 228 100 ? ? ? ?
8 18.1 17 256 110 ? ? ? ?
9 20.4 18 284 120 ? ? ? ?
10 21.7 19 312 130 ? ? ? ?
11 23 20 340 140 ? ? ? ?
12 24.3 21 368 150 ? ? ? ?
13 25.6 22 396 160 ? ? ? ?
14 26.9 23 424 170 ? ? ? ?
15 28.2 24 452 180 ? ? ? ?
16 29.5 25 480 190 ? ? ? ?
17 30.8 26 508 200 ? ? ? ?
18 32.1 27 536 210 ? ? ? ?
19 33.4 28 564 220 ? ? ? ?
20 34.7 29 592 230 ? ? ? ?
21 36 30 620 240 ? ? ? ?
22 37.3 31 648 250 ? ? ? ?
23 38.6 32 676 260 ? ? ? ?
24 39.9 33 704 270 ? ? ? ?
25 41.2 34 732 280 ? ? ? ?
26 42.5 35 760 290 ? ? ? ?
27 43.8 36 788 300 ? ? ? ?
28 45.1 37 816 310 ? ? ? ?
29 46.4 38 844 320 ? ? ? ?
30 47.7 39 872 330 ? ? ? ?